Venezuela, Bolivarian Republic of vs Zambia: Average cost of multi drug-resistant tuberculosis treatment
Venezuela, Bolivarian Republic of
674 constant 2022 US$
in 2024
Zambia
600 constant 2022 US$
in 2024
Venezuela, Bolivarian Republic of rank
70th
Zambia rank
72nd
Average cost of multi drug-resistant tuberculosis treatment over time
- Venezuela, Bolivarian Republic of
- Zambia
How they compare
Venezuela, Bolivarian Republic of currently reports 674 constant 2022 US$ against 600 constant 2022 US$ in Zambia, a difference of 74 constant 2022 US$.
That makes Venezuela, Bolivarian Republic of's figure about 1.1 times Zambia's.
The two have swapped places 1 time across 8 shared years of data; in 2017 it was Zambia ahead.
Venezuela, Bolivarian Republic of ranks 70th and Zambia ranks 72nd of 92 countries.
Zambia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Venezuela, Bolivarian Republic of | Zambia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 840.33 constant 2022 US$ | 5,822 constant 2022 US$ | 4,982 constant 2022 US$ | Zambia |
| 2020s | 1,372 constant 2022 US$ | 3,356 constant 2022 US$ | 1,984 constant 2022 US$ | Zambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of multi drug-resistant tuberculosis treatment, Venezuela, Bolivarian Republic of or Zambia?
- Venezuela, Bolivarian Republic of, at 674 constant 2022 US$ against 600 constant 2022 US$ in Zambia as of 2024.
- What is the difference in average cost of multi drug-resistant tuberculosis treatment between Venezuela, Bolivarian Republic of and Zambia?
- 74 constant 2022 US$, with Venezuela, Bolivarian Republic of ahead.
- How many years of comparable data are there for Venezuela, Bolivarian Republic of and Zambia?
- 8 years are reported by both, from 2017 to 2024.
- How do Venezuela, Bolivarian Republic of and Zambia rank globally for average cost of multi drug-resistant tuberculosis treatment?
- Venezuela, Bolivarian Republic of ranks 70th and Zambia ranks 72nd of 92 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of multi drug-resistant tuberculosis treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.